Boggs, Douglas L.
Surti, Toral
Gupta, Aarti
Gupta, Swapnil
Niciu, Mark
Pittman, Brian
Schnakenberg Martin, Ashley M.
Thurnauer, Halle
Davies, Andrew
D’Souza, Deepak C.
Ranganathan, Mohini
Funding for this research was provided by:
Stanely Medical Research Institute (07TGS-1082)
Article History
Received: 23 January 2018
Accepted: 15 March 2018
First Online: 5 April 2018
Compliance with ethical standards
:
: Support granted by the Stanely Medical Research Institute.Mohini Ranganathan has in the past 3 years or currently received research grant support administered through Yale University School of Medicine from Insys Therapeutics and Pfizer Inc. Deepak Cyril D’Souza has in the past 3 years or currently received research grant support administered through Yale University School of Medicine from Pfizer Inc. Pfizer, Inc. had a role in the design and conduct of the study: collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; and the decision to submit the manuscript for publication. Andrew Davies is a founder and full time employee of STI Pharmaceuticals Ltd (UK). Douglas Boggs, Aarti Gupta, John Cahill, Brian Pittman, Ashley Schnakenberg Martin, Halle Thurnauer, Swapnil Gupta, and Toral Surti report no financial relationships with commercial interests.